Aadi Bioscience Inc

AADI10 Dec 2024
Healthcare
$2.42
+0.02 (+2.07%)
Lowest Today
$2.41
Highest Today
$2.47
Today’s Open
$2.42
Prev. Close
$2.42
52 Week High
$5.54
52 Week Low
$1.21
To Invest in Aadi Bioscience Inc

Aadi Bioscience Inc

Healthcare
AADI10 Dec 2024
+0.02 (+2.07%)
1M
3M
6M
1Y
5Y
Low
$2.41
Day’s Range
High
$2.47
2.41
52 Week Low
$1.21
52-Week Range
52 Week High
$5.54
1.21
1 Day
-
1 Week
-0.8%
1 month return
+17.06%
3 month return
+38.76%
6 month return
+39.54%
1 Year return
-49.89%
3 Years return
-89%
5 Years return
-70.82%
10 Years return
-
Institutional Holdings
venBio Select Advisor LLC
11.56
BML Capital Management LLC
8.11
Longwood Capital Partners LLC
7.5
EcoR1 Capital, LLC
7.49
Vanguard Group Inc
3.11
Vanguard Total Stock Mkt Idx Inv
2.03
Renaissance Technologies Corp
1.87

Market Status

Fundamentals
Market Cap
59.65 mln
PB Ratio
0.87
PE Ratio
0
Enterprise Value
-2.03 mln
Total Assets
132.42 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Aadi Bioscience, Inc., a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa. The company is also involved in evaluating FYARRO in cancers, including indications targeting specific genomic alterations that activate the mTOR pathway. Aadi Bioscience, Inc. was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Organisation
Aadi Bioscience Inc
Employees
53
Industry
Biotechnology
CEO
Mr. David J. Lennon Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities